Integra LifeSciences reports Q3 2026 earnings, cites flood impact and revises Q4 outlook
Integra LifeSciences Holdings Corp announced third‑quarter 2026 revenue of $411.2 million, up 2.3% year‑over‑year, and adjusted earnings per share of $0.59. The company disclosed an approximately $7 million revenue hit from flood damage at its Cincinnati facility and completed a $2.1 billion debt refinancing after quarter‑end. It lowered its fourth‑quarter revenue guidance to $413 million‑$433 million and reaffirmed full‑year revenue guidance of $1.634 billion‑$1.654 billion.
Why it matters
The reduced Q4 revenue outlook signals a modest decline of up to 5.2% versus the prior year, which may pressure the stock price (the company’s shares fell 7.3% after the release). The refinancing extends debt maturities but adds roughly $8 million of interest expense in Q4, affecting near‑term earnings (the company said the refinancing will increase interest expense).
Key facts
- 1Q3 2026 revenue was $411.2 million, up 2.3% on a reported basis. stocktitan.net
- 2Adjusted EPS for Q3 was $0.59. stocktitan.net
- 3The results included an approximate $7 million revenue impact from flood damage at the Cincinnati facility. stocktitan.net
- 4Integra completed a $2.1 billion debt refinancing on October 19, 2026. stocktitan.net
- 5Fourth‑quarter revenue guidance was revised to $413 million‑$433 million. tradingview.com
- 6Full‑year 2026 revenue guidance remains $1.634 billion‑$1.654 billion. stocktitan.net
Summary written by AlphAI AI Desk from 20 of 26 sources. Not investment advice. Figures are as stated by the linked sources.